afatinib
boehringer ingelheim
['afatinib']
#asco22 abstract tps3180 describes a unique decentralized real world outcomes study of afatinib for #nrg1 fusion positive cancers. based on single patient protocol data. study ongoing! 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him